Загрузил gulmira_99_03

Постер образец

реклама
RELATIONSHIP OF METABOLIC SYNDROME AND RISK OF
DEVELOPING CARDIOVASCULAR DISEASE AND
DIABETES FOR POPULATION OF KAZAKHSTAN
KOICHUBEKOV B., SOROKINA M., LARYUSHINA YE., TURGUNOVA L.,
BAKIROVA R.
Karaganda State Medical University, Kazakhstan
Results
Goals
Metabolic syndrome (MS) is a
combination
of
medical
disorders that increase the risk
of developing cardiovascular
disease and diabetes. Some
studies have examined the
relationship between MS and
psychological risk factors such
as depression, anxiety, tension,
current perceived stress and
anger. We researched risks of
cardiovascular
diseases,
diabetes, the prevalence of
states
of
anxiety
and
depression among Central
Kazakhstan’s population with
MS.
Methods
3683
Central
Kazakhstan
citizens (2829 women and 854
men) aged 18 to 65 (45±12,71
(M±SD)) were examined. 543
people were diagnosed with
metabolic syndrome which
accounted for 14,74% (CI:
13,61;
15,93).
SCORE,
FINDRISK charts were used to
evaluate risks. PHQ-9 and
GAD-7 scales were used to
determine levels of depression
and anxiety.
Most important differences were determined for the prevalence of
diabetes and cardiovascular disease risks. Clearly increased risk
for diabetes was found for 19,7% (CI 16,34; 23,06) of people with
MS, almost 80,46% (CI 77,11; 83,81) had high risk of
cardiovascular disorders. Among women, diabetes risks were
more pronounced, whereas for men it were cardiovascular risks
FINDRISK PREVALENCE
MS
No MS
2% 5%
5% 1%
8%
Low
Mild
Moderate
High
Very high
20%
51%
35%
50%
23%
Depression states were common among people with MS - almost
25% of examined had moderate, moderately severe or severe
depressions. Severe anxiety level was observed for 18,05% (CI
14,8; 21,3).. Severe anxiety was observed more frequently among
women than among men (19,27% (CI 15,57; 22,97) and 12,75%
(CI 6,28; 19,22) respectively). However, almost 9% of men and
5,5% of women had moderately severe and severe depressions.
Depression prevalence (%)
30
25
20
15
28,4
Anxiety prevalence (%)
70
20,6
60,4
60
14,7
50
40
5,9
10
5
3
30
20,6
18
20
0
10
1
0
SCORE
PHQ-9
GAD-7
Minimal
Mild
Conclusions
The prevalence of metabolic syndrome in
Central Kazakhstan is significantly lower than in
Europe or the U.S. However, as is the case for
other countries, high risk of development of
diabetes and cardiovascular disorders are
observed among people with MS. Gathered
results confirm the role of anxiety and
depression conditions in MS development
Moderate Severe
Скачать